Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer.

Ronneburg, Henrike; Span, Paul N; Kantelhardt, Eva; Dittmer, Angela; Schunke, Dario; Holzhausen, Hans-Jürgen; Sweep, Fred C G J; Dittmer, Jürgen

Ronneburg, Henrike; Span, Paul N; Kantelhardt, Eva; Dittmer, Angela; Schunke, Dario; Holzhausen, Hans-Jürgen; Sweep, Fred C G J; Dittmer, Jürgen.

Affiliation

Ronneburg H; Klinik für Gynäkologie, Universität Halle, Halle, Saale, Germany.

Int J Oncol ; 36(2): 379-86, 2010 Feb.

Article in En | MEDLINE | ID: mdl-20043072

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/analysis; Breast Neoplasms/drug therapy; Carcinoma, Ductal, Breast/drug therapy; Guanine Nucleotide Dissociation Inhibitors/biosynthesis; Adult; Breast Neoplasms/genetics; Breast Neoplasms/metabolism; Carcinoma, Ductal, Breast/genetics; Carcinoma, Ductal, Breast/metabolism; Chemotherapy, Adjuvant; Cisplatin/therapeutic use; Drug Resistance, Neoplasm/genetics; Female; Fluorouracil/therapeutic use; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Methotrexate/therapeutic use; Middle Aged; Neoplasm Staging; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Treatment Outcome; rho-Specific Guanine Nucleotide Dissociation Inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Carcinoma, Ductal, Breast / Guanine Nucleotide Dissociation Inhibitors Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Int J Oncol Year: 2010 Type: Article Affiliation country: Germany

Search on Google

Add to My VHL

XML

PubMed Links